News Digest / Ticker: AZN

Ticker: AZN

07:06am, Monday, Feb 23, 2026
AstraZeneca (ST: AZN) secures FDA approval for Calquence combined with venetoclax, offering a fixed-duration oral treatment for chronic lymphocytic leukemia and small lymphocytic lymphoma based on robust Phase III results.